Home › Funds › Point72 Asset Management › MLTX
Point72 Asset Management position in MLTX
MOONLAKE IMMUNOTHERAPEUTICS · Health Care
Latest position (Q2 2026)1.16M sh
Reported value held$22.56M
Portfolio Weight0.09%
First reportedQ3 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 335.00K | $2.60M | New |
| Q1 2023 | 29.75K | $636.31K | New |
| Q4 2023 | 41.00K | $2.48M | New |
| Q4 2024 | 98.72K | $5.35M | New |
| Q2 2025 | 186.57K | $8.81M | New |
| Q2 2025 | 186.57K | $8.81M | New |
| Q3 2025 | 9.80K | $70.27K | Reduce |
| Q4 2025 | 772.50K | $10.18M | Add |
| Q1 2026 | 1.37M | $25.51M | Add |
| Q2 2026 | 1.16M | $22.56M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MLTX
- D. E. Shaw & Co 3.37M sh · $65.53M · Q2 2026
- Janus Henderson Group 3.45M sh · $64.30M · Q1 2026
- Two Sigma Investments 1.72M sh · $33.40M · Q2 2026
- JPMorgan Chase & Co 1.39M sh · $27.60M · Q2 2026
- BlackRock Inc 1.09M sh · $21.32M · Q2 2026
- Balyasny Asset Management 912.72K sh · $17.77M · Q2 2026
- Bank of America Corp 751.90K sh · $14.64M · Q2 2026
- Arrowstreet Capital 750.78K sh · $14.62M · Q2 2026
- Renaissance Technologies 643.27K sh · $12.52M · Q2 2026
- Millennium Management 636.19K sh · $12.39M · Q2 2026
- Morgan Stanley 563.60K sh · $10.97M · Q2 2026